These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 15840715

  • 21. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
    Furlong CE, Li WF, Costa LG, Richter RJ, Shih DM, Lusis AJ.
    Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
    [Abstract] [Full Text] [Related]

  • 22. Kinetic analysis of the in vitro inhibition, aging, and reactivation of brain acetylcholinesterase from rat and channel catfish by paraoxon and chlorpyrifos-oxon.
    Carr RL, Chambers JE.
    Toxicol Appl Pharmacol; 1996 Aug; 139(2):365-73. PubMed ID: 8806854
    [Abstract] [Full Text] [Related]

  • 23. Gastrointestinal nematode infection increases organophosphate toxicity in rats.
    Farid AS, Horii Y.
    Toxicol Lett; 2008 Jul 30; 180(1):33-7. PubMed ID: 18577432
    [Abstract] [Full Text] [Related]

  • 24. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos.
    Timchalk C, Poet TS, Kousba AA.
    Toxicology; 2006 Mar 01; 220(1):13-25. PubMed ID: 16343727
    [Abstract] [Full Text] [Related]

  • 25. Rat brain CYP2B-enzymatic activation of chlorpyrifos to the oxon mediates cholinergic neurotoxicity.
    Khokhar JY, Tyndale RF.
    Toxicol Sci; 2012 Apr 01; 126(2):325-35. PubMed ID: 22287024
    [Abstract] [Full Text] [Related]

  • 26. Effect of in vivo nicotine exposure on chlorpyrifos pharmacokinetics and pharmacodynamics in rats.
    Lee S, Poet TS, Smith JN, Busby-Hjerpe AL, Timchalk C.
    Chem Biol Interact; 2010 Mar 30; 184(3):449-57. PubMed ID: 20097188
    [Abstract] [Full Text] [Related]

  • 27. Expression of Th1/Th2 cytokines in human blood after in vitro treatment with chlorpyrifos, and its metabolites, in combination with endotoxin LPS and allergen Der p1.
    Duramad P, Tager IB, Leikauf J, Eskenazi B, Holland NT.
    J Appl Toxicol; 2006 Mar 30; 26(5):458-65. PubMed ID: 16871525
    [Abstract] [Full Text] [Related]

  • 28. Analysis of the additivity of in vitro inhibition of cholinesterase by mixtures of chlorpyrifos-oxon and azinphos-methyl-oxon.
    Richardson JR, Chambers HW, Chambers JE.
    Toxicol Appl Pharmacol; 2001 Apr 15; 172(2):128-39. PubMed ID: 11298499
    [Abstract] [Full Text] [Related]

  • 29. Enzyme-based assay for quantification of chlorpyrifos oxon in human plasma.
    Heilmair R, Eyer F, Eyer P.
    Toxicol Lett; 2008 Sep 15; 181(1):19-24. PubMed ID: 18655824
    [Abstract] [Full Text] [Related]

  • 30. Chlorpyrifos and its metabolites alter gene expression at non-cytotoxic concentrations in D3 mouse embryonic stem cells under in vitro differentiation: considerations for embryotoxic risk assessment.
    Estevan C, Vilanova E, Sogorb MA.
    Toxicol Lett; 2013 Feb 13; 217(1):14-22. PubMed ID: 23220036
    [Abstract] [Full Text] [Related]

  • 31. Metabolism of chlorpyrifos and chlorpyrifos oxon by human hepatocytes.
    Choi K, Joo H, Rose RL, Hodgson E.
    J Biochem Mol Toxicol; 2006 Feb 13; 20(6):279-91. PubMed ID: 17163483
    [Abstract] [Full Text] [Related]

  • 32. Chlorpyrifos oxon potentiates diacylglycerol-induced extracellular signal-regulated kinase (ERK 44/42) activation, possibly by diacylglycerol lipase inhibition.
    Bomser JA, Quistad GB, Casida JE.
    Toxicol Appl Pharmacol; 2002 Jan 01; 178(1):29-36. PubMed ID: 11781077
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of extension outgrowth in differentiating rat C6 glioma cells by chlorpyrifos and chlorpyrifos oxon: effects on microtubule proteins.
    Sachana M, Flaskos J, Sidiropoulou E, Yavari CA, Hargreaves AJ.
    Toxicol In Vitro; 2008 Aug 01; 22(5):1387-91. PubMed ID: 18417317
    [Abstract] [Full Text] [Related]

  • 34. Each lipase has a unique sensitivity profile for organophosphorus inhibitors.
    Quistad GB, Liang SN, Fisher KJ, Nomura DK, Casida JE.
    Toxicol Sci; 2006 May 01; 91(1):166-72. PubMed ID: 16449251
    [Abstract] [Full Text] [Related]

  • 35. Mass spectrometry identifies multiple organophosphorylated sites on tubulin.
    Grigoryan H, Schopfer LM, Peeples ES, Duysen EG, Grigoryan M, Thompson CM, Lockridge O.
    Toxicol Appl Pharmacol; 2009 Oct 15; 240(2):149-58. PubMed ID: 19632257
    [Abstract] [Full Text] [Related]

  • 36. An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat.
    Timchalk C, Kousba AA, Poet TS.
    Toxicol Sci; 2007 Aug 15; 98(2):348-65. PubMed ID: 17504771
    [Abstract] [Full Text] [Related]

  • 37. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: a critical review of the literature.
    Richardson RJ.
    J Toxicol Environ Health; 1995 Feb 15; 44(2):135-65. PubMed ID: 7531775
    [Abstract] [Full Text] [Related]

  • 38. Protein tyrosine adduct in humans self-poisoned by chlorpyrifos.
    Li B, Eyer P, Eddleston M, Jiang W, Schopfer LM, Lockridge O.
    Toxicol Appl Pharmacol; 2013 Jun 15; 269(3):215-25. PubMed ID: 23566956
    [Abstract] [Full Text] [Related]

  • 39. Concentration-dependent effects of chlorpyrifos oxon on peroxisome proliferator-activated receptor signaling in MCF-7 cells.
    Herriage S, Chen G, Pope C.
    Toxicol In Vitro; 2022 Feb 15; 78():105268. PubMed ID: 34756920
    [Abstract] [Full Text] [Related]

  • 40. Effects of chlorpyrifos oxon on M2 muscarinic receptor internalization in different cell types.
    Udarbe Zamora EM, Liu J, Pope CN.
    J Toxicol Environ Health A; 2008 Feb 15; 71(21):1440-7. PubMed ID: 18800293
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.